Injectable Cultured Bone Marrow–Derived Mesenchymal Stem Cells in Varus Knees With Cartilage Defects Undergoing High Tibial Osteotomy: A Prospective, Randomized Controlled Clinical Trial With 2 Years’ Follow-up
Intramyocardial Injection of Autologous Bone Marrow-Derived Ex Vivo Expanded Mesenchymal Stem Cells in Acute Myocardial Infarction Patients is Feasible and Safe up to 5 Years of Follow-up
Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival
Bone marrow-derived mesenchymal stromal cell results in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial)
The efficacy of targeted intraarterial delivery of concentrated autologous bone marrow containing mononuclear cells in the results of osteonecrosis of the femoral head: A five year follow-up study
Allogeneic Mesenchymal Stem Cell Transplantation in Severe and Refractory Systemic Lupus Erythematosus: 4 Years of Experience
Phase I trial: the use of autologous cultured adipose-derived stroma/stem cells to treat patients with non-revascularizable critical limb ischemia
Transplantation of autologous bone marrow mesenchymal stem cells in the results of complete and chronic cervical spinal cord injury
